Chinese herbal medicine for patients living with HIV in Guangxi province, China: A propensity score matching analysis of real-world data
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0304332 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jing Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, HIV Infections, Propensity Score, Antiretroviral Therapy, Highly Active. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: General Project of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
From 2004 onwards, the Chinese government has freely offered complimentary Chinese herbal medicine (CHM) to Chinese HIV/AIDS patients, alongside the prescribed first line therapy of highly active antiretroviral therapy (HAART). Thus, we aimed to explore the effectiveness and safety of CHM for patients with HIV/AIDS.
Methods
The data from the Guangxi pilot database and antiviral treatment sites database have been respectively developed into two datasets in this prospective cohort real-world study, the CHM combined HAART group (the integrated group) and the HAART group. A 1:1 propensity score matching (PSM) was performed and the longitudinal data were analyzed using a generalized estimating equation (GEE) model with an autocorrelation matrix and log link function attached to the Gamma distribution.
Results
A final sample of 629 patients, 455 and 174 in the integrated group and HAART group respectively, were obtained from the full dataset. As covariates for PSM, gender, age, baseline CD 4 + and CD 4 + / CD 8 + were assessed based on the results of the logistic regression analyses. Following PSM, 166 pairs from the full dataset were matched successfully, with 98 pairs in the baseline CD 4 + > 200 subgroup, and 55 pairs in the baseline CD 4 + ≤ 200 subgroup. In the full dataset, HAART group achieved higher CD4 + count ( OR = 1.119, 95% CI [1.018, 1.230]) and CD4 + /CD8 + ratio ( OR = 1.168, 95% CI [1.045, 1.305]) than the integrated group, so did in the CD4 + > 200 subgroup. For the CD 4 + ≤ 200 subgroup, the CD4 + ( OR = 0.825, 95% CI [0.694, 0.980]) and CD4 + /CD8 + ( OR = 0.826, 95% CI [0.684, 0.997]) of the integrated group were higher than those of the HAART group. The safety outcomes showed that there were no significant differences in BUN, ALT and AST levels between the groups but Cr showed significantly higher levels in HAART groups of all three datasets.
Conclusions
Compared to HAART alone, CHMs combined with HAART had better effects in improving the immune function of HIV/AIDS in patients with baseline CD 4 + count ≤ 200. The results of the two subgroups are in opposite directions, and chance does not explain the apparent subgroup effect. A study with larger sample size and longer follow-up period is warranted in order to increase study credibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
- Beijing Key Laboratory of the Innovative Development of Functional Staple and the Nutritional Intervention for Chronic Disease, China National Research Institute of Food & Fermentation Industries Co,. Ltd, Beijing, Chin…
- AIDS Centre, Ruikang Hospital, Guangxi University of Traditional Chinese Medicine, Nanning, Guangxi Zhuang Autonomous Region, China.
- Center for Disease Control and Prevention of Minhang District, Shanghai, China.
ORCID-Profile: Chen Shen, Jian-Ping Liu
Förderung
- General Project of the National Natural Science Foundation of China
Zitieren
APA
Li, J., Shen, C., Liu, Z. W., Pu, F. L., Cao, S. H., Zhang, Y., Han, X. F., Yuan, P., Duan, S. L., Jiang, F., & Liu, J. P. (2024). Chinese herbal medicine for patients living with HIV in Guangxi province, China: A propensity score matching analysis of real-world data. PLOS ONE. https://doi.org/10.1371/journal.pone.0304332
Vancouver
Li J, Shen C, Liu ZW, Pu FL, Cao SH, Zhang Y, et al. Chinese herbal medicine for patients living with HIV in Guangxi province, China: A propensity score matching analysis of real-world data. PLOS ONE. 2024. doi:10.1371/journal.pone.0304332
BibTeX
@article{Li2024,
author = {Li, Jing and Shen, Chen and Liu, Zhen-Wei and Pu, Feng-Lan and Cao, Shi-Huan and Zhang, Yue and Han, Xiao-Feng and Yuan, Peng and Duan, Sheng-Lin and Jiang, Feng and Liu, Jian-Ping},
title = {Chinese herbal medicine for patients living with HIV in Guangxi province, China: A propensity score matching analysis of real-world data},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0304332}
}
EUVIMED